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Sickle Cell Anaemia (SCA), one of the most common autosomal recessive hereditary anemia, is caused by a mutation in the beta-globin gene 
(HBB:c.20A>T) on 11p15.5. This mutation originates a hemoglobin variant named Hb S, as opposed to the normal adult Hb A.  
Hb S  ability to polymerize when deoxygenated gives rise to abnormal sickled red blood cells  (Fig.1).  
SCA is characterized by recurrent episodes of severe vaso-occlusion, haemolysis and infection. Several genetic and environmental modifiers have 
been suggested to modulate the onset and course of this disease (1).  
As part of a wider research on the development and validation of vaso-occlusion early predictors in SCA, we have studied the association between 
three haemolysis biomarkers (serum LDH, total bilirubin and reticulocyte count) and the inheritance of several genetic variants of candidate genes 
related to Hb Fetal level, red blood cell vascular adhesion and vascular tonus, as well as a common alpha-thalassaemia determinant, in a 
longitudinally observed series of paediatric SCA patients. 
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Subjects: 99 paediatric SCA  (SS) patients (median current age of 9.9 
years) followed-up in two general hospitals in Greater Lisbon area 
(median follow-up/patient of 5.0 years).  
Haemolysis biomarkers: LDH and total bilirrubin level and 
reticulocyte count.  
Candidate gene genotyping:  Forty-one genetic polymorphisms (34 
SNP, 6 indel, 1 STR) in the following loci have been typed: BCL11A, 
CD36, EDN1, HBA, HBB cluster (including HBG),  HBS1L-MYB, ITGA4, 
HMOX1,  NOS3, THBS1 and VCAM1. 
Statistical analysis: Association studies were performed using T test 
ANOVA  parametric tests (LDH, total bilirrubin) or Mann-
Whitney/Kuskal-Wallis non-parametric tests (reticulocyte count), all 
performed with SPSS v20.0 software.  A correction for multiple 
testing (false discovery rate) was done . 
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  Patients clinical data at steady-state have been captured to a database.  
  Forty one genetic variants within 11 candidate genes were characterized. 
  Association studies between candidate genotypes and haemolysis biomarkers were performed. 
  The following  significant associations were observed (Table I, Fig. 2)  
Cell vascular adhesion  
VCAM1 and CD36 are adhesion molecules able to promote blood cells adhesion to vascular endothelium. Some genetic variants of their corresponding genes were found 
associated with SCA haemolysis severity. VCAM1_gene_haplotype 7 was found associated with higher levels of LDH, suggesting a relation between this variant and a sub-
phenotype characterised by more severe haemolysis. Contrarely, heterozygosity for VCAM1_promotor_haplotype 9 was found associated with lower levels of total bilirubin 
revealing a protective effect against haemolysis. Also the rs1984112_G allele at CD36 gene revealed to be associated with higher levels of reticulocyte count, a likely more distal 
consequence of an increased haemolysis status.  
Vascular tonus 
NOS3 encodes nitric oxide synthase 3, which in endothelial cells generates NO, a gas with potent vasodilation and antiadhesive properties. The rs2070744_T allele at NOS3 seems 
to have a protective effect on SCA haemolysis as it was found associated with lower bilirubin levels. 
Alpha-thalassaemia 
Low levels of haemolysis, measured by low levels of total bilirubin and reticulocyte count were found associated with the presence of the 3.7 kb deletion alpha-thalassaemia 
determinant at HBA gene. SCA patients who co-inherited the deletion have reduced haemolysis owing to a lower intracellular concentration of HbS that in turn decreases HbS 
polymer-induced cellular damage. 
 
On the whole, our findings suggest a complex genetic architecture for the haemolytic endophenotype in SCA involving multiple pathways, namely control of vascular cell adhesion, 
NO synthesis and erythrocyte volume and haemoglobinisation. 
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Table I. Association between candidate gene variants and haemolysis markers in sickle cell anaemia 
a) The  first position represents the ancestral allele. 
b) Individual patients levels measured in steady state and averaged for the whole corresponding follow-up period. 
c) Hapl X = Non-hapl 9.  
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Fig. 2. Number of SCA patients with 
(+) or without (-) the genetic 
variant at (A) VCAM, (B) HBA and 
NOS3, or (C) CD36 and HBA with 
serum LDH, total bilirubin and 
reticulocyte levels in the two 
extreme quartiles (Q1,Q4), 
respectively. 
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The lifelong haemolytic anaemia is known to be a distinct hallmark of SCA clinical course. In this 
study a statistically significant association was found between biochemical or cellular correlates 
of different stages of the haemolytic phenotype and  the following genetic determinants: 
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